Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

about

Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.

P2860

Q53116342-3E270A6A-E90A-4DE0-9300-6030B6075E6B

P2860

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

Item

http://www.wikidata.org/entity/Q38966445

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

@en

type

Item

label

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

@en

prefLabel

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

@en

P1476

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients

@en

P2093

Jos A van der Hage

http://www.w3.org/2001/XMLSchema#string

Katarzyna Jóźwiak

http://www.w3.org/2001/XMLSchema#string

Marion M Deken

http://www.w3.org/2001/XMLSchema#string

Max F Madu

http://www.w3.org/2001/XMLSchema#string

Michel W J M Wouters

http://www.w3.org/2001/XMLSchema#string

P2860

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Final version of 2009 AJCC melanoma staging and classification

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Nivolumab in previously untreated melanoma without BRAF mutation

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters.

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.

20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters

P2888

s10434-017-5803-9

P304

1997-2005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-5803-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander C.J. van Akkooi

P577

2017-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083753558

http://www.w3.org/2001/XMLSchema#string

P698

28188500

http://www.w3.org/2001/XMLSchema#string

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

about

P2860

P2860

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698